My watch list
my.chemeurope.com  

my.chemeurope.com

With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.

  • My watch list
  • My saved searches
  • My saved topics
  • My newsletter
Register free of charge
Login  
eng  
DeutschEnglishFrançaisEspañol

DiaGenic



DiaGenic ASA
Public (OSE: DIAG)
Founded1998
HeadquartersOslo, Norway
Area servedGlobal
Key peopleErik Christensen (CEO)
Ingrid Alfheim (Chairman)
IndustryPharmeceuticals
ServicesDiagnostic tests
RevenueNOK 60,000 (2006)
Operating incomeNOK -23.3 million (2006)
ProfitNOK -22.7 million (2006)
Websitediagenic.com

DiaGenic (OSE: DIAG) is a Norwegian pharmaceutical company. It aims to develope tests for early diagnosis of deseases where only early intervention is nessesary for successful treatment. It has patented methods to indentify disease-specific gene signatures from sample material like blood. The company is based in Oslo and listed on the Oslo Stock Exchange.

Large amounts of the research is funded by the Research Council of Norway.

 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "DiaGenic". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE